Neonatal disorders often require urgent and effective interventions due to the vulnerability of the patient population. Traditional clinical trials may expose neonates to less effective treatments for the sake of maintaining statistical balance. RAR helps mitigate this ethical issue by shifting the odds in favor of more successful treatments as data emerges, potentially improving outcomes for newborns involved in the trial.
